CIBC Private Wealth Group
MBOT icon

CIBC Private Wealth Group’s Microbot Medical MBOT Stock Holding History

CIBC Private Wealth Group’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.96M Buy
1,480,000
+26,000
+2% +$61.6K 0.01% 507
2025
Q3 		$4.43M Buy
1,454,000
+842,000
+138% +$2.63M 0.01% 447
2025
Q2 		$1.54M Buy
+612,000
New +$1.46M ﹤0.01% 596

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

CIBC Private Wealth Group's MBOT Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Microbot Medical (MBOT) stake by 1.8% in Q4 2025, buying an estimated $61.6K and bringing the position to 1,480,000 shares worth $2.96M. The position accounts for 0.01% of the portfolio, ranked #507.

CIBC Private Wealth Group first reported a position in MBOT in Q2 2025 and has held it in 3 quarters since. The position peaked at $4.43M in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.

  • CIBC Private Wealth Group held 1,480,000 shares of Microbot Medical worth $2.96M as of Q4 2025.
  • CIBC Private Wealth Group bought 26,000 Microbot Medical shares in Q4 2025, an estimated $61.6K.
  • Microbot Medical made up 0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #507 holding.
  • CIBC Private Wealth Group first reported a position in Microbot Medical in Q2 2025 and has held it in 3 quarters since.
  • CIBC Private Wealth Group's Microbot Medical position peaked at $4.43M in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.